Cross-Site Scripting in IBM Aspera Faspex Affects Multiple Versions
CVE-2025-3423

5.4MEDIUM

Key Information:

Vendor

IBM
Status
Aspera Faspex
Vendor
CVE Published:
13 April 2025

What is CVE-2025-3423?

IBM Aspera Faspex version 5.0.0 to 5.0.11 contains a cross-site scripting vulnerability that enables authenticated users to inject arbitrary JavaScript code into the Web UI. This exploitation can modify intended functionalities and potentially expose sensitive information such as user credentials sessions. System administrators should take immediate action to mitigate the risks associated with this vulnerability.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Aspera Faspex 5.0.0 <= 5.0.11

References

https://www.ibm.com/support/pages/node/7230757
vendor-advisorypatch

CVSS V3.1

Score:
5.4
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.